Redeye reinforces its positive view on CombinedX following the acquisition of M3CS. Although the acquisition, at first sight, looks somewhat high-risk – a large acquisition with weak profitability – we believe the combination of a low EV/S, senior consultants, and a software platform well-known to CombinedX makes the acquisition appealing.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

CombinedX - Substantial Acquisition Strengthening the Infor M3 Offering

© Modular Finance, source Nordic Press Releases